Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice

Journal of Neuroinflammation

Volumn 10, Issue 1, 2013, Pages

  Lawson, Marcus A ^a   McCusker, Robert H ^a   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOPOLYSACCHARIDE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; TUMOR NECROSIS FACTOR; CASPASE INHIBITOR; CYTOKINE; INTERLEUKIN 1BETA; SUCROSE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; FORCED SWIM TEST; HUMIDITY; INNATE IMMUNITY; LOCOMOTION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGOMERIZATION; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SUCROSE PREFERENCE TEST; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; BODY WEIGHT; BRAIN LEVEL; C57BL MOUSE; CHEMICALLY INDUCED; DIAGNOSTIC USE; DRUG EFFECTS; ENZYMOLOGY; FOOD PREFERENCE; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KNOCKOUT MOUSE; METABOLISM; MOTOR ACTIVITY; PSYCHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SWIMMING;

ANIMALS; ANTIGENS, CD11B; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN CHEMISTRY; CASPASE 1; CASPASE INHIBITORS; CYTOKINES; DEPRESSION; FOOD PREFERENCES; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; REAL-TIME POLYMERASE CHAIN REACTION; SUCROSE; SWIMMING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876784736     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-54     Document Type: Article

References (54)

1. Smith RS: The macrophage theory of depression. Medical hypotheses 1991, 35:298-306.
2. Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA: The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol 2012, 92:959-975.
3. Raison CL, Miller AH: Is depression an inflammatory disorder Curr Psychiatry Rep 2011, 13:467-475.
4. Bodenheimer T, Chen E, Bennett HD: Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job Health Aff 2009, 28:64-74.
5. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B: Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
6. Hindle JV: Ageing, neurodegeneration and Parkinson's disease. Age Ageing 2010, 39:156-161.
7. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM: Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 2007, 3:186-191.
8. Catena-Dell'Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D: Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development Curr Med Chem 2011, 18:245-255.
9. Rothwell NJ, Luheshi GN: Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000, 23:618-625.
10. Goshen I, Kreisel T, Ben-Menachem-Zidon O, Licht T, Weidenfeld J, Ben-Hur T, Yirmiya R: Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 2008, 13:717-728.
11. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, Kelley KW, Dantzer R: Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009, 14:511-522.
12. O'Connor JC, Andre C, Wang Y, Lawson MA, Szegedi SS, Lestage J, Castanon N, Kelley KW, Dantzer R: Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci 2009, 29:4200-4209.
13. Maes M, Song C, Yirmiya R: Targeting IL-1 in depression. Expert Opin Ther Targets 2012, 16:1097-1112.
14. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009, 65:732-741.
15. Dinarello CA: Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 117:3720-3732.
16. Norman GJ, Karelina K, Zhang N, Walton JC, Morris JS, Devries AC: Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol Psychiatry 2010, 15:404-414.
17. Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V: Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40:171-176.
18. Yao J, Johnson RW: Induction of interleukin-1 beta-converting enzyme (ICE) in murine microglia by lipopolysaccharide. Brain Res Mol Brain Res 1997, 51:170-178.
19. Li P, Allen H, Banerjee S, Seshadri T: Characterization of mice deficient in interleukin-1 beta converting enzyme. J Cell Biochem 1997, 64:27-32.
20. Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009, 10:241-247.
21. Maslanik T, Mahaffey L, Tannura K, Beninson L, Greenwood BN, Fleshner M: The inflammasome and Danger Associated Molecular Patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain Behav Immun 2012, 28:54-62.
22. Fleshner M: Stress-evoked sterile inflammation, danger associated molecular patterns (DAMPs), microbial associated molecular patterns (MAMPs) and the inflammasome. Brain Behav Immun 2013, 27:1-7.
23. Burgess W, Gheusi G, Yao J, Johnson RW, Dantzer R, Kelley KW: Interleukin-1beta-converting enzyme-deficient mice resist central but not systemic endotoxin-induced anorexia. Am J Physiol 1998, 274:R1829-R1833.
24. Yao JH, Ye SM, Burgess W, Zachary JF, Kelley KW, Johnson RW: Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccharide. Am J Physiol 1999, 277:R1435-R1443.
25. Besedovsky HO, del Rey A: Interactions between immunological cells and the hypothalamus pituitary-adrenal axis: an example of neuroendocrine immunoregulation. Recenti Prog Med 1988, 79:300-304.
26. Besedovsky HO, del Rey A: The cytokine-HPA axis feed-back circuit. Z Rheumatol 2000, Suppl 2:II/26-II/30.
27. Goshen I, Yirmiya R: Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 2009, 30:30-45.
28. Nestler EJ, Hyman SE: Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
29. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA: Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 1995, 267:2000-2003.
30. Lawson MA, Kelley KW, Dantzer R: Intracerebroventricular administration of HIV-1 Tat induces brain cytokine and indoleamine 2,3-dioxygenase expression: a possible mechanism for AIDS comorbid depression. Brain Behav Immun 2011, 25:1569-1575.
31. Fanklin GPKBJ: The Mouse Brain in Stereotaxic Coordinates. 2nd edition. Waltham, MA: Academic; 2001.
32. Porsolt RD, Brossard G, Hautbois C, Roux S: Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. In Curr Protoc Neurosci. Edited by: Crawley JN. Hoboken, NJ: John Wiley and Sons; 2001. [Chapter 8:Unit 8 10A]
33. Li P, Allen H, Banerjee S, Franklin S, Herzog L, Johnston C, McDowell J, Paskind M, Rodman L, Salfeld J: Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995, 80:401-411.
34. Koo JW, Duman RS: IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 2008, 105:751-756.
35. Craft TK, DeVries AC: Role of IL-1 in poststroke depressive-like behavior in mice. Biol Psychiatry 2006, 60:812-818.
36. Lamkanfi M, Dixit VM: The inflammasomes. PLoS Pathog 2009, 5:e1000510.
37. Iwata M, Ota KT, Duman RS: The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav Immun 2013.
38. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Chronic pain-associated depression: antecedent or consequence of chronic pain A review. Clin J Pain 1997, 13:116-137.
39. Lepine JP, Briley M: The epidemiology of pain in depression. Hum Psychopharmacol 2004, Suppl 1:S3-S7.
40. Marchand F, Perretti M, McMahon SB: Role of the immune system in chronic pain. Nat Rev Neurosci 2005, 6:521-532.
41. Bluthe RM, Laye S, Michaud B, Combe C, Dantzer R, Parnet P: Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci 2000, 12:4447-4456.
42. Bluthe RM, Dantzer R, Kelley KW: Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res 1992, 573:318-320.
43. Crawley JN: Exploratory behavior models of anxiety in mice. Neurosci Biobehav Rev 1985, 9:37-44.
44. Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C: Cytokine signals propagate through the brain. Mol Psychiatry 2000, 5:604-615.
45. Quan N, Stern EL, Whiteside MB, Herkenham M: Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 1999, 93:72-80.
46. Quan N, Sundar SK, Weiss JM: Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol 1994, 49:125-134.
47. Stern EL, Quan N, Proescholdt MG, Herkenham M: Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide. J Neuroimmunol 2000, 109:245-260.
48. Dantzer R, Konsman JP, Bluthe RM, Kelley KW: Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent Auton Neurosci 2000, 85:60-65.
49. Taishi P, Churchill L, De A, Obal F Jr, Krueger JM: Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo. Brain Res 2008, 1226:89-98.
50. Depino A, Ferrari C, Pott Godoy MC, Tarelli R, Pitossi FJ: Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions. J Neuroimmunol 2005, 168:96-110.
51. Kaster MP, Gadotti VM, Calixto JB, Santos AR, Rodrigues AL: Depressive-like behavior induced by tumor necrosis factor-alpha in mice. Neuropharmacology 2012, 62:419-426.
52. Simen BB, Duman CH, Simen AA, Duman RS: TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol Psychiatry 2006, 59:775-785.
53. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35.
54. McCusker RH, Kelley KW: Immune-neural connections: how the immune system's response to infectious agents influences behavior. J Exp Biol 2013, 216:84-98.